ChemicalBook > Product Catalog >API >Antineoplastic agents >Other antineoplastic Drugs >Rituximab

Rituximab

Rituximab Suppliers list
Company Name: Biochempartner
Tel: 0086-13720134139
Email: candy@biochempartner.com
Products Intro: Product Name:Rituximab
CAS:174722-31-7
Purity:98% HPLC LCMS Package:10G;20G
Company Name: Chembest Research Laboratories Limited  
Tel: +86(0)21-20908456
Email: sales@biochembest.com; market@biochembest.com
Products Intro: Product Name:Rituximab
CAS:174722-31-7
Purity:95% SEC-HPLC Package:50mg;100mg Remarks:Biochemical Reagents; Pharmaceutical Intermediates
Company Name: LGM Pharma  
Tel: 1-(800)-881-8210
Email: inquiries@lgmpharma.com
Products Intro: Product Name:RituxiMab
CAS:174722-31-7
Purity:Typically NLT 98%
Company Name: Wuhan Sunrise Technology Development Co., Ltd.  
Tel: +86 (27) 8331-4682 / +86 13554138826
Email: whsrtech@vip.163.com,whsrtech@whsrtech.com
Products Intro: Product Name:RituxiMab
CAS:174722-31-7
Purity:97% Package:2Mg/vial, 20Mg/vial, 100mg/vial Remarks:for lab use only, in stock
Company Name: Beijing HuaMeiHuLiBiological Chemical   
Tel: 010-56205725;010-86181995
Email: waley188@sohu.com
Products Intro: Product Name:RituxiMab
CAS:174722-31-7
Purity:99% Package:25kg
Rituximab Basic information
Product Name:Rituximab
Synonyms:Immunoglobulin G1;Hsdb 7455;Immunoglobulin G 1 (human-mouse monoclonal idec-C2B8 gamma1-chain anti-human antigen cd 20), disulfide with human-mouse monoclonal idec-C2B8 kappa-chain, dimer;Mab thera;Mabthera;Rituxan;Unii-4F4X42syq6;Retuxin
CAS:174722-31-7
MF:C6416H9874N1688O1987S44
MW:0
EINECS:
Product Categories:
Mol File:Mol File
Rituximab Structure
Rituximab Chemical Properties
Safety Information
MSDS Information
Rituximab Usage And Synthesis
UsesAntineoplastic (microtubule inhibitor); monoclonal antibody.
Brand nameRituxan (IDEC).
Rituximab Preparation Products And Raw materials
Tag:Rituximab(174722-31-7) Related Product Information
Rivaroxaban Trastuzumab Atezolizumab Denosumab (usan) CETUXIMAB Evolocumab NA ipilimumab Unii-fys6T7F842 Ustekinumab Nivolumab Avastin Daratumumab OMALIZUMAB Lambrolizumab Dulaglutide Unii-A3ulp0F556 Infliximab